Broad support: Broadcom rose 3.1 percent to $246.94 Friday after it said it will repurchase up to $12 billion of its stock.
Unmade bed: Shares in home goods retailer Bed Bath & Beyond plunged 19 percent to $17.44 Thursday after it gave a weak forecast for the fiscal year. The company also said it expects its earnings to decline next year. Shares closed the week at $17.28.
Deal doubts: Bristol-Myers Squibb fell 3.2 percent to $58.26 and Pfizer rose 1.7 percent to $36.41 Thursday after an analyst for Citi Investment Research said a deal between the two drugmakers isn’t likely to happen. Analyst Andrew Baum said he met with Pfizer’s top executives Wednesday and that they have “no interest” in Bristol-Myers or other major deals right now. Bristol-Myers closed Friday at $58.65 while Pfizer finished at $36.32.
Deal bounce: VeriFone Systems surged 52 percent to $22.79 Tuesday after it agreed to be bought by Francisco Partners and British Columbia Investment Group. The investment group will pay $23.04 a share for VeriFone. Shares closed the week at $22.77.
Deal letdown: Shares of medical and security imaging equipment maker Analogic dropped 13.4 percent to $83.20 Wednesday after it agreed to be bought by Altaris Capital Partners for $84 a share, which was much less than investors had hoped. Shares finished the week at $83.50.
Earnings bounce: Delta Air Lines shares rose 3 percent to $53.03 Thursday after it reported a stronger-than-expected first quarter as passenger and cargo revenue improved. The stock closed Friday at $52.92.